diabetes
Broad Institute, Novo Nordisk Foundation Launch Center to Study Genomic Mechanisms of Disease
The center, which is being funded by a $47.5 million commitment from the foundation, will initially focus on type 2 diabetes and obesity.
Rare Mutations Associated With Significantly Higher Risk of Type 2 Diabetes in New Study
University of Cambridge and Broad Institute researchers found what could be a direct connection between clonal mosaicism and metabolic health.
Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets
Starting with a large GWAS, researchers incorporated chromatin accessibility data and other clues to find key variants, immune cell types, and treatment targets.
GWAS Across Ancestries Uncovers Novel Genetic Loci Linked to Glycemic Traits
The researchers estimated that if their analysis had only focused on individuals of European descent, they would have missed two dozen novel loci.
Syntegra Teams With Vanderbilt's Nashville Biosciences on Biobank Data Analysis for Drug R&D
Data analysis firm Syntegra will work with NashBio to produce and validate synthetic data from the BioVU biobank, starting with type 2 diabetes.
Jun 24, 2020
Apr 22, 2020
Roche Diagnostics Q1 Sales Essentially Flat
Mar 16, 2020
Mar 13, 2020
Tempus Closes $100M Series G Round
Oct 2, 2019